PETTAZZONI, PIERGIORGIO

PETTAZZONI, PIERGIORGIO  

Mostra records
Risultati 1 - 14 di 14 (tempo di esecuzione: 0.015 secondi).
Titolo Data di pubblicazione Autore(i) File
4-Hydroxynonenal (HNE), a product of lipide peroxidation, inhibits telomerase activity in Caco-2, a colon cancer cell line, by the inhibition of E-Box activity of the h-TERT promoter 2008 PIZZIMENTI S; BERARDI D; TOALDO C; PETTAZZONI P; DIANZANI MU; MENEGATTI E; BARRERA G
Antitumor activity of nanosponge-encapsulated camptotechin in human prostate tumors. 2010 Rosalba Minelli; Roberta Cavalli; Roberto Fantozzi; Chiara Dianzani; Piergiorgio Pettazzoni ; Roberto Pili
Antitumor activity of nanosponge-encapsulated camptothecin in human prostate tumors 2011 Minelli R; Cavalli R; Fantozzi R; Dianzani C; Pettazzoni P; Ellis L; Shen L; Pili R
AS601245, an Anti-Inflammatory JNK Inhibitor, Strengthens the Effects of Clofibrate and Affects Gene Expression Profile, in CaCo-2 Colon Cancer Cells 2010 Barrera G; Cerbone A; Toaldo C; Pizzimenti S; Pettazzoni P; Dianzani C; Minelli R; Roma G; Dianzani MU; Ferretti C
Cholesteryl butyrate solid lipid nanoparticles inhibit adhesion and migration of colon cancer cells 2011 Minelli, R; Zara, Gp; Serpe, L; Barrera, G; Pettazzoni, P; Fantozzi, R; Dianzani, C.
Combined Antitumoral Efficacy of the Histone Deacetilase Inhibitor LBH589 and Lipids Peroxidation End Product 4-Hydroxinonenal(HNE)on PC3 Prostate Cancer Cell. 2010 Pettazzoni P; Pizzimenti S; Toaldo C; Ciamporcero E; Dianzani MU; Sotomayor P; Tagliavacca L; Pil R; Barrera G.
Combined antitumoral efficacy of the histone deacetilase inhibitor LBH589 and the lipid peroxidation end product 4-hydroxynonenal (HNE) on PC3 prostate cancer cell. 2010 PETTAZZONI P.; PIZZIMENTI S.; TOALDO C.; DIANZANI M.U.; SOTOMAYOR P.; TAGLIAVACCA L.; PILI R.; BARRERA G.
Effetti del 4-idrossinonenale, un’aldeide prodotta dalla perossidazione lipidica, sull’espressione dei microRNA in cellule leucemiche umane HL-60 2008 PIZZIMENTI S.; FERRACIN M.; SABBIONI S.; TOALDO C.; PETTAZZONI P.; DIANZANI M.U.; NEGRINI M.; BARRERA G.
Identification of 4-Hydroxynonenal-alpha-enolase adducts in HL-60 human leukemic cells: inhibition of plasminogen binding 2008 GENTILE F; PIZZIMENTI S; ARCARO A; PETTAZZONI P; D’ANGELO D; MAMONE G; FERRANTI P; TOALDO C; CENTRANGOLO GP; FORMISANO S; DIANZANI MU; UCHIDA K; BARRERA G
MicroRNA expression profiling during human leukemic HL-60 cell differentiation induced by 4-Hydroxynonenal, a product of lipid peroxidation 2008 PIZZIMENTI S; FERRACIN M; SABBIONI S; TOALDO C; PETTAZZONI P; DIANZANI MU; NEGRINI M; BARRERA G
Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands inhibit telomerase activity and h-TERT expression in CaCo-2 colon cancer cells 2008 TOALDO C; PIZZIMENTI S; PETTAZZONI P; DIANZANI MU; BARRERA G
Rosiglitazone and AS601245 Decrease Cell Adhesion and Migartion Trhougt modulation of specific Gene Expression in Human Colon Cancer Cells. 2012 R. Minelli;A.Cerbone;C. Toaldo;E. Ciamporcero;S. Pizzimenti; P. Pettazzoni; M. Dianzani; C. Ferretti; C. Dianzani; G. Barrera
Rosiglitazone, Alone or in Combination with AS601245, an Anti-Inflammatory JNK Inhibitor, Affects Apoptosis, Differentiation and Cell Adhesion in CaCo-2 Human Colon Cancer Cells Through Modulation of Specific Gene Expressions. 2010 Toaldo C; Cerbone A; Pizzimenti S; Pettazzoni P; Dianzani C; Minelli R; Roma G; Dianzani MU; Ferretti C; Barrera G
Targeting Cell Cycle Through Combination of the Histone Deacetylase Inhibitor, LBH589,and Lipids Peroxidation End Product,4-Hydroxnonenal (HNE), in PC3 Prostate Cancer Cells. 2010 Pettazzoni P; Pizzimenti S; Toaldo C; Ciamporcero E; Dianzani M.U.; Sotomayor P; Tagliavacca L; Pil R; Barrera G.